Table 3.
Reasons Why Recommended Nodule Evaluation Deviated From Guideline Recommendations
| Variable | Any Deviation From Guideline Recommendations (n = 37) | Less Intense Recommendation (n = 8) | More Intense Recommendation (n = 29) |
|---|---|---|---|
| Competing diagnoses | 15 | 0 | 15 |
| Different data or criteria used | 2 | 1 | 1 |
| Patient considered lower risk | 2 | 2 | 0 |
| Semi-solid nodule or other radiographic appearance | 6 | 3 | 3 |
| Pretransplantation evaluation | 2 | 0 | 2 |
| Could not be determineda | 10 | 2 | 8 |
Counts will not add up to total sample because some individuals will have multiple documented reasons for guideline nonadherent care.
a
Could not determine from the clinical documentation.